FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034774830> ?p ?o ?g. }

• W2034774830 endingPage "196" @default.
• W2034774830 startingPage "188" @default.
• W2034774830 abstract "Current diagnostic studies [radioiodine uptake and serum thyroglobulin (Tg) levels] for residual or metastatic thyroid tissue in patients with differentiated thyroid carcinoma require a hypothyroid status necessary for adequate endogenous TSH stimulation. However, almost all patients have symptoms of clinical hypothyroidism during this period. As shown in the present study, recombinant human TSH (rhTSH) allows stimulation of 131I uptake and Tg release from residual thyroid tissue in euthyroid patients. To assess safety, dosage, and preliminary efficacy, comparison was made of the stimulation of 131I uptake and Tg release after rhTSH administration and after T3 withdrawal in 19 patients after a recent thyroidectomy for differentiated thyroid carcinoma. Various doses (10-40 U) of rhTSH were injected im for 1-3 days in patients receiving suppressive doses of T3. Twenty-four hours after the last dose of rhTSH, 1-2 mCi 131I were administered, followed by a neck and whole body scan 48 h later. After discontinuing T3 for a median period of 19 days (range, 15-28), endogenous serum TSH levels were markedly elevated, and the patients were given a second dose of 131I and rescanned 48 h later. The injections of rhTSH were tolerated well. No major adverse effects were reported; nausea was reported in 3 (16%) and vomiting in 1 of the patients treated with high doses. The quality of life, as measured by two psychometric scales, was far better during rhTSH treatment than after T3 withdrawal. The peak levels of serum TSH (mean +/- SD) after a single dose of 10, 20, or 30 U were 127 +/- 19, 309 +/- 156, and 510 +/- 156 mU/L, respectively, and occurred 2-8 h after injection. Twenty-four hours after the injection, TSH levels decreased to 83 +/- 31, 173 +/- 73, and 463 +/- 148 mU/L in these treatment groups, respectively. The quality of the thyroid scans and the number of sites of abnormal 131I uptake were similar after rhTSH treatment and in the hypothyroid scans in 12 (63%) patients. Two additional sites of uptake in the chest and one in the thyroid bed, not visible on the hypothyroid scans, were identified in 3 (16%) patients after rhTSH. In 1 patient a focus of uptake was better visualized after rhTSH than after withdrawal. In 3 (16%) other patients, 1 lesion in the chest and 2 in the neck were seen only after T3 withdrawal.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2034774830 created "2016-06-24" @default.
• W2034774830 creator A5004522280 @default.
• W2034774830 creator A5008957622 @default.
• W2034774830 creator A5011324262 @default.
• W2034774830 creator A5026473240 @default.
• W2034774830 creator A5028469549 @default.
• W2034774830 creator A5039332127 @default.
• W2034774830 creator A5045007611 @default.
• W2034774830 creator A5063674941 @default.
• W2034774830 creator A5066773921 @default.
• W2034774830 creator A5069500337 @default.
• W2034774830 date "1994-01-01" @default.
• W2034774830 modified "2023-09-26" @default.
• W2034774830 title "Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)." @default.
• W2034774830 cites W135320823 @default.
• W2034774830 cites W1580274923 @default.
• W2034774830 cites W1790559018 @default.
• W2034774830 cites W1967419297 @default.
• W2034774830 cites W1968437962 @default.
• W2034774830 cites W1978495417 @default.
• W2034774830 cites W1987722074 @default.
• W2034774830 cites W1988793600 @default.
• W2034774830 cites W1993291446 @default.
• W2034774830 cites W1996821185 @default.
• W2034774830 cites W2001677896 @default.
• W2034774830 cites W2005303099 @default.
• W2034774830 cites W2010286510 @default.
• W2034774830 cites W2013235616 @default.
• W2034774830 cites W2018340093 @default.
• W2034774830 cites W2019472675 @default.
• W2034774830 cites W2023913045 @default.
• W2034774830 cites W2024541437 @default.
• W2034774830 cites W2026216627 @default.
• W2034774830 cites W2029872319 @default.
• W2034774830 cites W2038532502 @default.
• W2034774830 cites W2081170992 @default.
• W2034774830 cites W2102022889 @default.
• W2034774830 cites W2123885054 @default.
• W2034774830 cites W2145333714 @default.
• W2034774830 cites W2145859723 @default.
• W2034774830 cites W2253590988 @default.
• W2034774830 cites W2326459399 @default.
• W2034774830 cites W2472214878 @default.
• W2034774830 cites W68555182 @default.
• W2034774830 doi "https://doi.org/10.1210/jcem.78.1.8288703" @default.
• W2034774830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8288703" @default.
• W2034774830 hasPublicationYear "1994" @default.
• W2034774830 type Work @default.
• W2034774830 sameAs 2034774830 @default.
• W2034774830 citedByCount "113" @default.
• W2034774830 countsByYear W20347748302012 @default.
• W2034774830 countsByYear W20347748302013 @default.
• W2034774830 countsByYear W20347748302015 @default.
• W2034774830 countsByYear W20347748302018 @default.
• W2034774830 countsByYear W20347748302021 @default.
• W2034774830 countsByYear W20347748302022 @default.
• W2034774830 crossrefType "journal-article" @default.
• W2034774830 hasAuthorship W2034774830A5004522280 @default.
• W2034774830 hasAuthorship W2034774830A5008957622 @default.
• W2034774830 hasAuthorship W2034774830A5011324262 @default.
• W2034774830 hasAuthorship W2034774830A5026473240 @default.
• W2034774830 hasAuthorship W2034774830A5028469549 @default.
• W2034774830 hasAuthorship W2034774830A5039332127 @default.
• W2034774830 hasAuthorship W2034774830A5045007611 @default.
• W2034774830 hasAuthorship W2034774830A5063674941 @default.
• W2034774830 hasAuthorship W2034774830A5066773921 @default.
• W2034774830 hasAuthorship W2034774830A5069500337 @default.
• W2034774830 hasConcept C126322002 @default.
• W2034774830 hasConcept C134018914 @default.
• W2034774830 hasConcept C197934379 @default.
• W2034774830 hasConcept C24998067 @default.
• W2034774830 hasConcept C2777074255 @default.
• W2034774830 hasConcept C2777195454 @default.
• W2034774830 hasConcept C2777546739 @default.
• W2034774830 hasConcept C2778835679 @default.
• W2034774830 hasConcept C2780580376 @default.
• W2034774830 hasConcept C2993294228 @default.
• W2034774830 hasConcept C526584372 @default.
• W2034774830 hasConcept C71315377 @default.
• W2034774830 hasConcept C71924100 @default.
• W2034774830 hasConceptScore W2034774830C126322002 @default.
• W2034774830 hasConceptScore W2034774830C134018914 @default.
• W2034774830 hasConceptScore W2034774830C197934379 @default.
• W2034774830 hasConceptScore W2034774830C24998067 @default.
• W2034774830 hasConceptScore W2034774830C2777074255 @default.
• W2034774830 hasConceptScore W2034774830C2777195454 @default.
• W2034774830 hasConceptScore W2034774830C2777546739 @default.
• W2034774830 hasConceptScore W2034774830C2778835679 @default.
• W2034774830 hasConceptScore W2034774830C2780580376 @default.
• W2034774830 hasConceptScore W2034774830C2993294228 @default.
• W2034774830 hasConceptScore W2034774830C526584372 @default.
• W2034774830 hasConceptScore W2034774830C71315377 @default.
• W2034774830 hasConceptScore W2034774830C71924100 @default.
• W2034774830 hasIssue "1" @default.
• W2034774830 hasLocation W20347748301 @default.
• W2034774830 hasLocation W20347748302 @default.
• W2034774830 hasOpenAccess W2034774830 @default.

• next